Apothecary Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 19-06-2024
- Paid Up Capital ₹ 2.00 M
as on 19-06-2024
- Company Age 10 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.65 Cr
as on 19-06-2024
- Satisfied Charges ₹ 1.20 Cr
as on 19-06-2024
- Revenue 151.07%
(FY 2019)
- Profit 131.19%
(FY 2019)
- Ebitda 90.50%
(FY 2019)
- Net Worth 166.67%
(FY 2019)
- Total Assets 3.53%
(FY 2019)
About Apothecary Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹2.65 Cr. The company has closed loans amounting to ₹1.20 Cr, as per Ministry of Corporate Affairs (MCA) records.
Satej Patil and Bhagyashri Patil serve as directors at the Company.
- CIN/LLPIN
U74999PN2014PTC153045
- Company No.
153045
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Nov 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Kolhapur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Apothecary Pharmaceuticals Private Limited offer?
Apothecary Pharmaceuticals Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Nutritional Supplements, Animal Medicines & Health Care, Veterinary Medicines, Bird Food, Poultry & Animal Food, Animal Feed Supplement, Veterinary Injections, Veterinary Drugs, Sulfur Fertilizers, Copper Sulfate Powder.
Who are the key members and board of directors at Apothecary Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satej Patil  | Director | 10-Nov-2014 | Current |
| Bhagyashri Patil | Director | 23-Apr-2016 | Current |
Financial Performance of Apothecary Pharmaceuticals.
Apothecary Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 151.07% increase. The company also saw a substantial improvement in profitability, with a 131.19% increase in profit. The company's net worth Soared by an impressive increase of 166.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Apothecary Pharmaceuticals?
In 2019, Apothecary Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Dec 2023 | ₹2.00 Cr | Open |
Others Creation Date: 21 Jul 2023 | ₹4.50 M | Open |
Axis Bank Limited Creation Date: 03 Aug 2020 | ₹2.00 M | Open |
How Many Employees Work at Apothecary Pharmaceuticals?
Unlock and access historical data on people associated with Apothecary Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apothecary Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apothecary Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
